Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 2/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | MMP12 | P39900 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL27839155 | 0.91 | MAPK1 (0.42) | CA2CA1SMN1; SMN2MAPK1EPHX1 | |
| SCHEMBL6856461 | 0.84 | MAPK1 (0.38) | CA2CA1SMN1; SMN2MAPK1EPHX1 | |
| SCHEMBL13271935 | 0.81 | MAPK1 (0.39) | CA2CA1SMN1; SMN2MAPK1EPHX1 | |
| SCHEMBL13271977 | 0.78 | MAPK1 (0.37) | CA2CA1SMN1; SMN2MAPK1 | |
| SCHEMBL25708327 | 0.78 | CA2 (0.52) | CA2CA1SMN1; SMN2MAPK1EPHX1 | |
| SCHEMBL10789031 | 0.78 | CA2 (0.52) | CA2CA1SMN1; SMN2MAPK1EPHX1 | |
| SCHEMBL14477969 | 0.77 | CA1 (0.46) | CA2CA1SMN1; SMN2MAPK1EPHX1 | |
| SCHEMBL17853345 | 0.77 | CA1 (0.41) | CA2CA1SMN1; SMN2MAPK1EPHX1 | |
| SCHEMBL19810864 | 0.76 | CA1 (0.50) | CA2CA1SMN1; SMN2MAPK1EPHX1 | |
| SCHEMBL9944590 | 0.76 | SMN1; SMN2 (0.34) | CA2SMN1; SMN2MAPK1EPHX1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250343260-A1 | SOLID ELECTROLYTES | IMEC VZW (BE) | 2025-11-06 | — | — | US | disclosed |
| EP-4280335-B1 | SOLID ELECTROLYTES | IMEC VZW (BE) | 2025-05-07 | — | — | EP | disclosed |
| US-12018000-B2 | Lithium salts of cyano-substituted imidazole for lithium ion batteries | HYDRO-QUéBEC (CA) | 2024-06-25 | — | — | US | disclosed |
| US-12018000-B2 | Lithium salts of cyano-substituted imidazole for lithium ion batteries | HYDRO-QUéBEC (CA) | 2024-06-25 | — | — | US | disclosed |
| CN-109321157-B | Adhesive composition for optical film, adhesive layer for optical film, optical film with adhesive layer, and image display device | 日东电工株式会社 | 2024-03-12 | — | — | CN | disclosed |
| WO-2023222511-A1 | SOLID ELECTROLYTES | IMEC VZW (BE) | 2023-11-23 | — | — | WO | disclosed |
| EP-4280335-A1 | SOLID ELECTROLYTES | Imec VZW (BE) | 2023-11-22 | — | — | EP | disclosed |
| US-20230276792-A1 | SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND CLOQUINTOCET-MEXYL | BAYER AKTIENGESELLSCHAFT (DE) | 2023-09-07 | — | — | US | disclosed |
| US-11738004-B2 | Indomethacin analogs for the treatment of castrate-resistant prostate cancer | VANDERBILT UNIVERSITY (US) | 2023-08-29 | — | — | US | disclosed |
| US-20230161252-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-25 | — | — | US | disclosed |
| EP-1479676-A1 | Benzimidazole-derivatives as factor xa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2004-11-24 | — | — | EP | disclosed |
| EP-1479675-A1 | Indazole-derivatives as factor Xa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2004-11-24 | — | — | EP | disclosed |
| EP-1479679-A1 | Triazole-derivatives as factor Xa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2004-11-24 | — | — | EP | disclosed |
| EP-1479680-A1 | Azaindole derivatives as Factor Xa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2004-11-24 | — | — | EP | disclosed |
| WO-2004056815-A1 | PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004050636-A2 | IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-06-17 | — | — | WO | disclosed |
| EP-1414088-A1 | NOVEL ONIUM SALT, ELECTROLYTE FOR NONAQUEOUS CELL CONTAINING THE NOVEL ONIUM SALT FOR NONAQUEOUS CELL, AND METHOD FOR OPTIMIZING NEGATIVE ELECTRODE USING ELECTROLYTE CONTAINING ONIUM SALT | Tokuyama Corporation (JP) | 2004-04-28 | — | — | EP | disclosed |
| WO-2003044014-A1 | INDOLE-2-CARBOXAMIDES AS FACTOR XA INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-05-30 | — | — | WO | disclosed |
| US-20030096163-A1 | Non aqueous electrolyte secondary battery | SANYO ELECTRIC CO., LTD. (JP) | 2003-05-22 | — | — | US | disclosed |
| EP-0399291-A2 | Substituted (Quinoline-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides , process for their preparation and their use in medicines | BAYER AG (DE) | 1990-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11738004-B2 | Indomethacin analogs for the treatment of castrate-resistant prostate cancer | AKR1C3, AKR1C4, AKR1C1 | CA2 569/4885CA1 244/4885SMN1; SMN2 4767/4885 |
| US-20230276792-A1 | SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND CLOQUINTOCET-MEXYL | AADAC, ABAT, ABCG2 | CA2 285/4885CA1 2513/4885SMN1; SMN2 4291/4885 |
| US-12018000-B2 | Lithium salts of cyano-substituted imidazole for lithium ion batteries | HCN2, HCN3, HLCS | CA2 49/4885CA1 292/4885SMN1; SMN2 3749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.